Related Experiment Video
Updated: Sep 13, 2025

A Calcium Phosphate-Induced Mouse Abdominal Aortic Aneurysm Model
Published on: November 18, 2022
PP2Acα Deficiency in Vascular Smooth Muscle Cells Accelerates Aortic Aneurysm and Dissection by Regulating KLF4
Wei-Peng Hu1,2,3,4,5, Ze-Yu Cai2,6, Qing-Le Li7
1Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing, 100191, China.
Abstract:
Aortic aneurysm and dissection (AAD) are life-threatening cardiovascular diseases with limited effective medical treatments. Protein phosphatase 2A (PP2A), the most abundant serine/threonine phosphatase in eukaryotes, is pivotal in regulating intracellular signaling. This study investigates the role of PP2A in the pathogenesis of AAD. Analysis of available datasets revealed that PP2Acα is the most significantly downregulated PP2A subunit in human and mouse aneurysm tissues. Vascular smooth muscle cell (VSMC)-specific PP2Acα knockout exacerbates β-Aminopropionitrile (BAPN)-induced aortic dissection and elastase-induced abdominal aortic aneurysm in mice. Collagen-based contraction assays, Western blot, and gelatin zymography confirmed that the deficiency of PP2Acα results in decreased contractility, contractile markers, and elevated production of matrix metallopeptidase 2 (MMP2) in VSMCs. Furthermore, PP2Acα deficiency promoted VSMC phenotypic switching through stabilizing Kruppel-like factor 4 (KLF4). Mechanistically, PP2Acα binds to and dephosphorylates protein kinase B 1 (AKT1), thereby reducing phosphorylation of the AKT1 substrate KLF4 at Thr398. The deficiency of PP2Acα diminishes KLF4 phosphorylation-dependent ubiquitination and degradation, leading to the suppression of VSMC contractile gene transcription. The findings underscore a critical role for PP2Acα in regulating VSMC phenotypic switching and AAD progression by controlling KLF4 phosphorylation and ubiquitination, offering novel insights into the molecular pathogenesis underlying AAD.
Insights
Protein phosphatase 2A catalytic subunit alpha (PP2Acα) deficiency worsens aortic aneurysm and dissection (AAD). PP2Acα loss impairs vascular smooth muscle cell contractility and promotes disease progression by stabilizing KLF4.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Cellular Signaling
Background:
- Aortic aneurysm and dissection (AAD) are critical cardiovascular conditions lacking effective treatments.
- Protein phosphatase 2A (PP2A) is a key regulator of cellular signaling pathways.
- Understanding PP2A's role in AAD pathogenesis is crucial for developing new therapies.
Purpose of the Study:
- To investigate the role of PP2A, specifically the PP2Acα subunit, in the development of AAD.
- To elucidate the molecular mechanisms by which PP2Acα influences vascular smooth muscle cell (VSMC) function and AAD progression.
Main Methods:
- Analysis of human and mouse aneurysm tissue datasets.
- Generation of VSMC-specific PP2Acα knockout mouse models.
- In vivo induction of aortic dissection and aneurysm using BAPN and elastase.
- In vitro assays including collagen-based contraction, Western blot, and gelatin zymography.
Main Results:
- PP2Acα was significantly downregulated in human and mouse aneurysm tissues.
- VSMC-specific PP2Acα knockout exacerbated AAD in mice.
- PP2Acα deficiency decreased VSMC contractility, reduced contractile markers, and increased MMP2 production.
- PP2Acα deficiency stabilized KLF4, promoting VSMC phenotypic switching and suppressing contractile gene transcription via AKT1 signaling.
Conclusions:
- PP2Acα plays a critical protective role in regulating VSMC function and preventing AAD.
- PP2Acα deficiency promotes AAD by controlling KLF4 phosphorylation and subsequent degradation.
- Targeting PP2Acα-KLF4 interaction may offer a novel therapeutic strategy for AAD.
More Related Videos
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Related Concept Videos
Peripheral Artery Disease I: Introduction
Atherosclerosis I: Introduction
Anaphase Promoting Complex